Henry O. Gosebruch, EVP, Chief Strategy Officer at AbbVie Inc. (ABBV), sold 45,900 shares at $146.81 ($6.8M) on 2022-03-01, disclosed to the SEC on 2022-03-02.
Seasonal sale ($6.8M) by EVP, Chief Strategy Officer — this insider has traded ABBV in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $146.81 | 15,733 | $2.3M | 34.2% |
| 2 | $146.81 | 15,733 | $2.3M | 34.2% |
| 3 | $147.60 | 5,167 | $763K | 11.3% |
| 4 | $147.60 | 5,167 | $763K | 11.3% |
| 5 | $148.71 | 4,000 | $595K | 8.8% |
| 6 | $149.38 | 100 |
| $15K |
| 0.2% |
| Total | $147.16 avg | 45,900 | $6.8M | 100% |
| Filing → |
| ABBV | SELL | 2022-05-20 | $13.0M | — | Filing → |
| ABBV | SELL | 2022-03-01 | $2.2M | — | Filing → |
| ABBV | SELL | 2020-11-24 | $4.0M | — | Filing → |